CTSI’s Office of Discovery and Translation issues the 7th Translational Product Development Fund RFA funding cycle to support projects that advance research discoveries towards commercializable products. Apply now for support for projects on the path to form a start-up or license agreement, and focused on product development.
CTSI’s Office of Discovery and Translation (ODAT) has released a special Request for Applications (RFA) to advance the development of promising early-stage therapeutics. The intention of funding is to better position these projects to be competitive for follow-on funding through other internal or external funding programs and for successful commercialization. Learn more and apply.
A new CTSI funding opportunity is available for University of Minnesota researchers to support the development of innovations that address challenges faced by family and unpaid/informal caregivers.
This program provides funding in two stages to full-time University of Minnesota faculty to prepare and implement prospective clinical pilot studies for focused clinical research questions and the data collected is expected to inform subsequent larger clinical trials.
CTSI is accepting Letters of Intent through noon, April 30 for its junior faculty scholar program that aims to develop the next generation of clinical and translational investigators through structured training with a mentored, multidisciplinary clinical research emphasis.
A new RFA is available through the Translational Product Development Fund for projects that have the potential to be commercialized through the formation of a start-up company or execution of a license agreement with an established commercial entity; apply by Feb. 7.
CTSI will provide up to 10 undergraduate students and up to 10 doctoral-level students opportunities in its summer 2018 research career development programs; apply by Feb. 5.
There’s a new funding opportunity for University of Minnesota researchers developing diagnostics and treatments for rare diseases, thanks to the recent release of an RFA from CTSI’s Translational Grant Program. CTSI anticipates funding up to two projects, with each project receiving as much as $50,000 in direct costs for one year.
CTSI has released a new RFA for the Translational Product Development Fund, which supports projects that have the potential to be commercialized, such as projects that may lead to the formation of a start-up company or execution of a license agreement with an established commercial entity.
CTSI will provide up to 10 undergraduate students and up to five doctoral-level students opportunities in its summer 2017 research career development programs; apply by January 19, 2017.
- Academic Health Center / Health Sciences (37)
- Accelerating discoveries (56)
- Advancing child health discoveries (27)
- Biomedical informatics (24)
- Biostatistical support (17)
- BLS (BioNet) (8)
- BMIP (27)
- BPIC (14)
- CEARCH (68)
- Clinical data repository (12)
- Clinical research professional (10)
- Clinical research services (47)
- Clinical trial management system / OnCore (11)
- Clinical trials (26)
- Community engagement in research (75)
- Community Engagement Studio (2)
- Community Research Institute (1)
- CTR Portal (5)
- CTRS (36)
- CTSA consortium (17)
- CTSI event (32)
- CTSI-Ed (94)
- Early-stage research (39)
- Fairview Research Administration (12)
- Grant (83)
- i2b2 (5)
- Interdisciplinary research (10)
- M Health (6)
- MARCH (1)
- Multisite research (14)
- NCATS (23)
- NIH (26)
- ODAT (48)
- Participate in a study (9)
- PCORI (3)
- Pilot funding (38)
- REDCap (7)
- Regulatory support (12)
- Research career & workforce development (95)
- Research mentor (43)
- Research participant recruitment (15)
- Research Toolkit (3)
- Research tools (40)
- ResearchMatch (2)
- RFA (31)
- Specimen procurement (7)
- StudyFinder (10)
- Team Science (39)
- University of Minnesota (166)